November 23, 2017 5:59 AM ET

Pharmaceuticals

Company Overview of Novan, Inc.

Key Executives for Novan, Inc.

NameBoard RelationshipsTitleAge
G. Kelly Martin 29 RelationshipsInterim Chief Executive Officer and Director58
Nathan Stasko Ph.D.14 RelationshipsCo-Founder, President, Chief Scientific Officer & Director37
Robert Alexander Ingram 174 RelationshipsExecutive Chairman74
William L. Hodges CPA1 RelationshipsInterim Chief Financial Officer62
Stanley Hollenbach BS,J.D.No RelationshipsSenior Vice President of Research & Development--
View More Key Executives

Novan, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert Alexander Ingram 174 RelationshipsNovan, Inc.74
G. Kelly Martin 29 RelationshipsNovan, Inc.58
Nathan Stasko Ph.D. 14 RelationshipsNovan, Inc.37
Paula Brown Stafford 13 RelationshipsNovan, Inc.52
Robert J. Keegan 20 RelationshipsXerox Corporation70
View All Board Members

Novan, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee W. Kent Geer16 Relationships3 Executives
Compensation Committee Robert J. Keegan20 Relationships3 Executives
Nominating Committee Sean Edward Murphy28 Relationships3 Executives
Corporate Governance Committee Sean Edward Murphy28 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
380.6K
Bonus
400.9K
Total Short Term Compensation
526.5K
Total Value of Options
7.7M
Compensation as of Fiscal Year
Novan, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Cann Group Limited Appoints Neil Belot as Director
November 22, 2017 12:46 AM ET
Flex Pharma, Inc. Announces the Resignation of Robert Hadfield as General Counsel, Effective November 29, 2017
November 21, 2017 10:09 PM ET
Scpharmaceuticals Inc. Announces Resignation of Jonathan Silverstein from the Board of Directors
November 21, 2017 9:41 PM ET
Revive Therapeutics Ltd. Appoints Bernie Doyle as Technical Advisor
November 21, 2017 12:00 PM ET
Sunil Healthcare Limited Announces Demise of S.N. Balasubramanian, Non-Executive Independent Director
November 21, 2017 8:18 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Novan, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.